Sign In
Buy LZAGY
$61.62
-1.35 (-2.14%)
At Close: Jun 03, 2026
Lonza Group AG (LZAGY) Q1 2026 Earnings Call Transcript
02:51pm, Friday, 08'th May 2026
Lonza Group AG (LZAGY) Q1 2026 Earnings Call Transcript
Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products
07:55am, Tuesday, 21'st Apr 2026
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development
Lonza: Structural Growth Intact, CHI Exit Strengthens Focus, Recent Weakness Reinforces Entry Opportunity
06:03am, Wednesday, 01'st Apr 2026
Lonza's FY2025 results exceeded expectations, with EBITDA growth significantly ahead of revenue, supported by operating leverage and margin recovery. The CHI divestment accelerates Lonza's transition
Lonza Group AG (LZAGY) Discusses Divestment of Capsules and Health Ingredients Business and Focus on CDMO Transformation Transcript
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG
12:30pm, Friday, 06'th Mar 2026
DALLAS & NEW YORK & LONDON & TOKYO--(BUSINESS WIRE)--Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire
Lonza Group Continues To Leverage Biopharma's Optimization Push
12:17pm, Thursday, 29'th Jan 2026
Lonza Group remains a leading CDMO, capitalizing on biopharma's shift to outsourced manufacturing and complex drug production. LZAGY delivered strong H2 results: 17% CDMO revenue growth, 28% EBITDA gr
Lonza Group AG (LZAGY) Q4 2025 Earnings Call Transcript
01:52pm, Wednesday, 28'th Jan 2026
Lonza Group AG (LZAGY) Q4 2025 Earnings Call Transcript
Lonza Group AG (LZAGY) Q3 2025 Earnings Call Transcript
02:17pm, Thursday, 23'rd Oct 2025
Lonza Group AG (OTCPK:LZAGY) Q3 2025 Earnings Call October 23, 2025 8:00 AM EDT Company Participants Philippe Deecke - Chief Financial Officer Conference Call Participants Zain Ebrahim - JPMorgan Chas
PHG vs. LZAGY: Which Stock Is the Better Value Option?
12:41pm, Monday, 06'th Oct 2025
Investors interested in stocks from the Medical - Products sector have probably already heard of Royal Philips (PHG) and Lonza Group Ag (LZAGY). But which of these two stocks offers value investors a
Here's Why Lonza Group (LZAGY) Is a Great 'Buy the Bottom' Stock Now
10:56am, Monday, 22'nd Sep 2025
Lonza Group (LZAGY) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean
Lonza Group AG (LZAGY) Q2 2025 Earnings Call Transcript
12:03pm, Wednesday, 23'rd Jul 2025
Lonza Group AG (OTCPK:LZAGY) Q2 2025 Earnings Conference Call July 23, 2025 8:00 AM ET Company Participants Philippe Deecke - Chief Financial Officer Wolfgang Wienand - Chief Executive Officer Confere
Lonza Group (LZAGY) Upgraded to Strong Buy: Here's Why
01:06pm, Wednesday, 28'th May 2025
Lonza Group (LZAGY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Lonza Group AG (LZAGY) Q1 2025 Earnings Call Transcript
01:27pm, Friday, 09'th May 2025
Lonza Group AG (OTCPK:LZAGY) Q1 2025 Earnings Conference Call May 9, 2025 9:00 AM ET Company Participants Philippe Deecke - Chief Financial Officer Conference Call Participants Zain Ebrahim - JPMorgan
Lonza Group Ag (LZAGY) is a Great Momentum Stock: Should You Buy?
01:05pm, Tuesday, 06'th May 2025
Does Lonza Group Ag (LZAGY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Lonza Group (LZAGY) Upgraded to Buy: Here's What You Should Know
01:05pm, Tuesday, 08'th Apr 2025
Lonza Group (LZAGY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
